CLOZAPINE - NEW RESEARCH ON EFFICACY AND MECHANISM OF ACTION

[1] ALTAR CA, 1986, BRAIN RES BULL, V16, P517

[2] ALTAR CA, 1988, N-S ARCH PHARMACOL, V338, P162

[3] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[4] SOME ATYPICAL NEUROLEPTICS INHIBIT [H-3] SCH 23390 BINDING INVIVO [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (01) : 143 - 144

[5] ANDEVRAN D, 1977, EUR J CLIN PHARMACOL, V11, P1

[6] Angst J., 1971, PHARMACOPSYCHIATRY, V4, P200

[7] CLINICAL IMPORTANCE OF D-1 AND D-2 RECEPTORS [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 402 - 406

[8] BERSANI G, 1986, CURR THER RES CLIN E, V40, P492

[9] BISCHOFF S, 1986, HIPPOCAMPUS, V3, P1

[10] RELATIONSHIPS BETWEEN CLINICAL AND BIOCHEMICAL EFFECTS OF MELPERONE AND THIOTHIXENE IN PSYCHOTIC WOMEN [J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1979, 227 (03): : 181 - 192

[1] ALTAR CA, 1986, BRAIN RES BULL, V16, P517

[2] ALTAR CA, 1988, N-S ARCH PHARMACOL, V338, P162

[3] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[4] SOME ATYPICAL NEUROLEPTICS INHIBIT [H-3] SCH 23390 BINDING INVIVO [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (01) : 143 - 144

[5] ANDEVRAN D, 1977, EUR J CLIN PHARMACOL, V11, P1

[6] Angst J., 1971, PHARMACOPSYCHIATRY, V4, P200

[7] CLINICAL IMPORTANCE OF D-1 AND D-2 RECEPTORS [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 402 - 406

[8] BERSANI G, 1986, CURR THER RES CLIN E, V40, P492

[9] BISCHOFF S, 1986, HIPPOCAMPUS, V3, P1

[10] RELATIONSHIPS BETWEEN CLINICAL AND BIOCHEMICAL EFFECTS OF MELPERONE AND THIOTHIXENE IN PSYCHOTIC WOMEN [J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1979, 227 (03): : 181 - 192